Inventor · disambiguated record
Matthew Duncan Selby
Also filed as: SELBY MATTHEW D · SELBY MATTHEW DUNCAN
17 granted patents·4 pending applications·94 citations·filing 2002–2020
92Inventor score
Top patents by PatentIndex Score
21 records- 0191US6933312B2Pyrazole derivativesAGOURON PHARMA·Filed 2003·Granted Aug 23, 2005·32 cites·7 claims
- 0287US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 0385US10906919B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2018·Granted Feb 2, 2021·2 cites·10 claims
- 0484US9932343B2Fused tricyclic benzimidazoles derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·10 cites·16 claims
- 0582US10202405B2Fused pentacyclic imidazole derivativesUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 12, 2019·4 cites·11 claims
- 0682US7109228B2Pyrazole derivativesAGOURON PHARMA·Filed 2002·Granted Sep 19, 2006·14 cites·35 claims
- 0779US7435728B2Pyrazole derivativesPFIZER·Filed 2005·Granted Oct 14, 2008·3 cites·29 claims
- 0877US9550737B2TNF -α modulating benzimidazolesUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 24, 2017·4 cites·10 claims
- 0975US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 1074US9475820B2Substituted imidazo[1,2-a]pyrazines as TNF activity modulatorsUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 25, 2016·3 cites·14 claims
- 1168US10004737B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jun 26, 2018·1 cites·8 claims
- 1267US12018021B2Thiophene derivatives for the treatment of disorders caused by IgEUCB Biopharma SRL·Filed 2019·Granted Jun 25, 2024·1 cites·15 claims
- 1367US11912721B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2020·Granted Feb 27, 2024·0 cites·16 claims
- 1460US8063044B2Pyrazole derivativesJONES LYN HOWARD·Filed 2008·Granted Nov 22, 2011·0 cites·26 claims
- 1554US2021380573A1Benzimidazolone Derivatives, and Analogues Thereof, as IL-17 ModulatorsUCB Biopharma SRL·Filed 2019·Application pending·0 cites
- 1651US2012029192A1Pyrazole DerivativesJONES LYN HOWARD·Filed 2011·Application pending·0 cites
- 1749US12391688B2Imidazopyridine derivatives as IL-17 modulatorsUCB Biopharma SRL·Filed 2020·Granted Aug 19, 2025·0 cites·10 claims
- 1845US2022073485A1Functionalised Amine Derivatives as IL-17 ModulatorsUCB Biopharma SRL·Filed 2019·Application pending·0 cites
- 1944US7157468B2Pyrazole derivativesPFIZER·Filed 2003·Granted Jan 2, 2007·0 cites·3 claims
- 2039US2004132793A1Pyrazole derivativesPFIZER·Filed 2003·Application pending·0 cites
- 2138US11052076B2Spirocyclic indolines as IL-17 modulatorsUCB Biopharma SRL·Filed 2018·Granted Jul 6, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Duncan Selby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →